Steven Gillis

Executive Chairman at Surface Logix LLC

Steven Gillis

Steven Gillis

Executive Chairman at Surface Logix LLC

Overview
Career Highlights

Theraclone Sciences, Inc.
Surface Logix LLC
Viral Logic Systems Technology Corp.

RelSci Relationships

1280

Number of Boards

57

Birthday

04/1954

Age

67

Contact Data
Trying to get in touch with Steven Gillis? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Steven Gillis likely has professional access to. A relationship does not necessarily indicate a personal connection.

Senior Managing Director & Chief Executive Officer at Accelerator Services Corp.

Relationship likelihood: Strong

Former President & Chief Executive Officer at Life Science Washington

Relationship likelihood: Strong

Co-Founder at Vir Biotechnology, Inc.

Relationship likelihood: Strong

Managing Director at OVP Venture Partners

Relationship likelihood: Strong

Co-Founder at Alexandria Real Estate Equities, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Theraclone Sciences, Inc.

Relationship likelihood: Strong

Founder at Faraday Pharmaceuticals, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at VBI Vaccines, Inc.

Relationship likelihood: Strong

Former Managing Director at Clarus Ventures LLC

Relationship likelihood: Strong

Co-Founder at Versant Venture Management LLC

Relationship likelihood: Strong

Paths to Steven Gillis
Potential Connections via
Relationship Science
You
Steven Gillis
Executive Chairman at Surface Logix LLC
Education
Ph.D.
Class of 1978

Founded in 1769, Dartmouth is a member of the Ivy League and consistently ranks among the world's greatest academic institutions. Dartmouth has forged a singular identity for combining its deep commitment to outstanding undergraduate liberal arts and graduate education with distinguished research and scholarship in the Arts & Sciences and its three leading professional schools—the Geisel School of Medicine, Thayer School of Engineering, and the Tuck School of Business.

B.A.
Class of 1975

Williams College is a private liberal arts college located in Williamstown, Massachusetts, United States. It was established in 1793 with funds from the estate of Ephraim Williams. Originally a men's college, Williams became co-educational in 1970. It is located in Williamstown, MA, USA.

Career History
Managing Director
2005 - Current

ARCH Venture Partners invests in companies located in the US. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with an investment size of $50 to $150 million and also makes co-investments.

Executive Chairman
Current

Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA.

Senior Advisor
Current

Accelerator Corp. invests in emerging life sciences opportunities. Through the global activities of their affiliates, the firm has access to new technologies and commercial opportunities developed at leading research institutions, universities and biotechnology companies around the world. Accelerator Corp. looks for companies that are milestone-driven and have a set of objectives designed to advance novel technologies rapidly from discovery to a proof-of-concept development stage that supports further financing.

Boards & Committees
Member, Board of Directors
Prior - 2016

13therapeutics is an American private company located in Portland, OR. The firm operates as health and science university. Thomas H. Bruggere is the current CEO of the firm.

Independent Non-Executive Director
1993 - 2012

Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand.

Chairman
Prior

Qwell Pharmaceuticals, Inc. developed small molecule drugs for oncology indications. It was a start-up biotechnology company devoted to small-molecule development derived from a plant source that have a potent ability to fight tumors and excess inflammation of skin cells. The company was founded in 2008 and was headquartered in Seattle, WA.

Member, Board of Directors
Prior - 2015

Benaroya Research Institute at Virginia Mason is a non-profit organization that operates as a medical research institute. It conducts reserach for eliminating autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis, and immune system diseases such as allergies and asthma. The company was founded in 1956 and is headquartered in Seattle, WA.

Political Donations
$1,500
2013
$1,500
2011
$1,500
2010
Transactions
Details Hidden

Evotec SE purchases Just - Evotec Biologics, Inc.

Details Hidden

Theraclone Sciences, Inc. raised money in a private placement transaction

Details Hidden

Theraclone Sciences, Inc. raised money in a private placement transaction

Investments
Details Hidden

OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA.

Details Hidden

Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT.

Details Hidden

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Public Holdings
Restricted data only for RelSci Enterprise users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Steven Gillis. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Steven Gillis's profile does not indicate a business or promotional relationship of any kind between RelSci and Steven Gillis.